Patrick M Schürch

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Circulating Tumor

Top Venues

EMBO molecular medicine

Nature communications

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Marco Losa, Marc Emmenegger, Pierre De Rossi, Patrick M Schürch, Tetiana Serdiuk, Niccolò Pengo, Danaëlle Capron, Dimitri Bieli, Niklas Bargenda, Niels J Rupp, Manfredi C Carta, Karl J Frontzek, Veronika Lysenko, Regina R Reimann, Petra Schwarz, Mario Nuvolone, Gunilla T Westermark, K Peter R Nilsson, Magdalini Polymenidou, Alexandre Pa Theocharides, Simone Hornemann, Paola Picotti, Adriano Aguzzi
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis. EMBO molecular medicine (2024)
Mattheus H E Wildschut, Julien Mena, Cyril Dördelmann, Marc van Oostrum, Benjamin D Hale, Jens Settelmeier, Yasmin Festl, Veronika Lysenko, Patrick M Schürch, Alexander Ring, Yannik Severin, Michael S Bader, Patrick G A Pedrioli, Sandra Goetze, Audrey van Drogen, Stefan Balabanov, Radek C Skoda, Massimo Lopes, Bernd Wollscheid, Alexandre P A Theocharides, Berend Snijder
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis. Nature communications 14 (1) (2023)
Kristopher R Bosse, Anna Maria Giudice, Maria V Lane, Brendan McIntyre, Patrick M Schürch, Guillem Pascual-Pasto, Samantha N Buongervino, Sriyaa Suresh, Alana Fitzsimmons, Adam Hyman, Maria Gemino-Borromeo, Jennifer Saggio, Esther R Berko, Alexander A Daniels, Jennifer Stundon, Megan Friedrichsen, Xin Liu, Matthew L Margolis, Marilyn M Li, Marni Brisson Tierno, Geoffrey R Oxnard, John M Maris, Yael P Mosse
Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma. Cancer discovery 12 (12) (2022)